Treatment of the Porphyrias: Mechanisms of Action
- 1 July 1981
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 77 (1) , 107-113
- https://doi.org/10.1111/1523-1747.ep12479285
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The Enzymatic Defect in Variegate PorphyriaNew England Journal of Medicine, 1980
- HqMATIN THERAPY AND LEUCOCYTE $delta;-AMINOLqVULINIC-ACID-SYNTHASE ACTIVITY IN PROLONGED ATTACK OF ACUTE PORPHYRIAThe Lancet, 1979
- Red-Cell Uroporphyrinogen Decarboxylase Activity in Porphyria Cutanea Tarda and in Other Forms of PorphyriaNew England Journal of Medicine, 1978
- Decreased Activity of Hepatic Uroporphyrinogen Decarboxylase in Sporadic Porphyria Cutanea TardaNew England Journal of Medicine, 1978
- Porphyria Cutanea Tarda in Three Generations of a Single FamilyNew England Journal of Medicine, 1978
- Erythropoietic Protoporphyria — Diagnosis and TreatmentNew England Journal of Medicine, 1977
- Chloroquine in the Treatment of Porphyria Cutanea TardaNew England Journal of Medicine, 1977
- The glucose effect: Carbohydrate repression of enzyme induction, RNA synthesis, and glucocorticoid activity — A role for cyclic AMP and cyclic GMPLife Sciences, 1975
- CONGENITAL ERYTHROPOIETIC PORPHYRIA: The Effect of Light ShieldingActa Paediatrica, 1973
- The Role of Iron in the Pathogenesis of Porphyria Cutanea TardaJournal of Clinical Investigation, 1972